Hillsdale Investment Management »

Arcutis Biotherapeutics shares owned by Hillsdale Investment Management

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Hillsdale Investment Management from 13F filings

Historical chart of Hillsdale Investment Management investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Hillsdale Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Hillsdale Investment Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.2M 179k 29.04

More positions owned by Hillsdale Investment Management

Rbc Cad (RY)
Cibc Cad (CM)
Tor Dom Bk Cad (TD)
Bk Nova Cad (BNS)
Shopify Inc cl a (SHOP)
Enerflex (EFXT)
Agnico (AEM)
Bank Of Montreal Cadcom (BMO)
Enbridge (ENB)
Barrick Mining Corp (B)
Centerra Gold (CGAU)
Ero Copper Corp (ERO)
NVIDIA Corporation (NVDA)
Wheaton Precious Metals Corp (WPM)
Fortis (FTS)

View all positions for Hillsdale Investment Management

Top funds holding Arcutis Biotherapeutics

Rubric Capital Management
Suvretta Capital Management
Frazier Life Sciences Management
BlackRock
Vanguard Group
Jennison Associates
State Street Corporation
Polar Capital Holdings
Gilder, Gagnon, Howe & Co
UBS Group
Geode Capital Management
Henderson Group
Pivotal bioVenture Partners Investment Advisor
D. E. Shaw & Co
Perpetual

View all funds holding Arcutis Biotherapeutics